Drug-Coated Balloon and In-Stent Restenosis: A Clinical Strategy to Manage Coronary Artery Diseases

نویسندگان

چکیده

Cardiovascular events are the most common cause of morbidity and mortality worldwide. Coronary artery diseases, including myocardial infarctions, prevalent among all populations. There multiple management strategies for coronary but stent implantation is effective interventions. Nevertheless, some patients develop restenosis intervened vessel, number constitutes about 10%-20% patients. In-stent leads to adverse effects that might end in sudden cardiac death. Restenosis forges a clinical challenge practicing physicians. A drug-coated balloon has propitious potential showing results comparable stents overcome in-stent restenosis. This review aims evaluate effectiveness advancement balloons treating as intervention, along with its benefits drawbacks.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Drug-coated balloon in combination with bare metal stent strategy for de novo coronary artery disease

BACKGROUND Studies examining the efficiency of drug-coated balloon (DCB) + bare metal stent (BMS) compared with stents alone for de novo lesions have reported inconsistent results. The present comprehensive meta-analysis of randomized controlled trials (RCTs) assessed and compared the clinical efficacy and safety of DCB + BMS with those of stents alone for de novo coronary artery disease. MET...

متن کامل

Paclitaxel-Coated Balloon for Recalcitrant In-Drug-Eluting Stent Restenosis.

C omplete percutaneous revascularization, including the treatment of complex lesions and chronic total occlusions, has become a frequent reality in interventional cardiology. Although the overall need for repeat revascularization due to drug-eluting stent (DES) restenosis remains in singledigit levels, in highly complex forms of coronary artery disease, itmay significantly compromise the long-t...

متن کامل

Paclitaxel-Coated Balloon Catheter Versus Paclitaxel-Coated Stent for the Treatment of Coronary In-Stent Restenosis

Background—Treatment of in-stent restenosis with paclitaxel-coated balloon catheter as compared with plain balloon angioplasty has shown surprisingly low late lumen loss at 6 months and fewer major adverse cardiac events up to 2 years. We compared the efficacy and safety of a paclitaxel-coated balloon with a paclitaxel-eluting stent as the current standard of care. Methods and Results—One hundr...

متن کامل

Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial.

BACKGROUND Drug-coated balloon angioplasty (DCBA) was shown to be superior to standard balloon angioplasty (POBA) in terms of restenosis prevention for de novo superficial femoral artery disease. For in-stent restenosis, the benefit of DCBA over POBA remains uncertain. METHODS AND RESULTS One hundred nineteen patients with superficial femoral artery in-stent restenosis and chronic limb ischem...

متن کامل

Long-term efficacy of drug-coated balloon for renal artery in-stent restenosis

https://doi.org/10.1016/j.ehj.2017.12.006 1110-2608/ 2017 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Peer review under responsibility of Egyptian Society of Cardiology. ⇑ Corresponding author at: Interventional Cardiology, A.O. Fatebenefratelli Milano, B...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Social Science Research Network

سال: 2021

ISSN: ['1556-5068']

DOI: https://doi.org/10.2139/ssrn.3780134